EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudie

Comparative Effectiveness of High‐Dose and Standard‐Dose Influenza Vaccines for Hospitalisation and Mortality in Adults Aged 65 and Older: An Updated Systematic Review and Meta‐Analysis

Bilal Wazir Khan iD, Muhammad Huzaifa Khattak, Muhammad Maaz Amjad, Shahreena Athar Siddiqui, Tayyaba Ikram Qazi, Hamdullah Rehmat, Muhammad Faaz Khan, Haris Wazir Khan, Affan Masaud Mian, Mohsin Ullah, Umer Zaryab Khan, Muhammad Abdur Rafay und 2 weitere

Reviews in Medical Virology · 2026-05 · 36 (3)

DOI: 10.1002/rmv.70158 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Reviews in Medical Virology, online erschienen am 29.04.2026. Verfasst von Bilal Wazir Khan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Khyber Medical College, Peshawar, Pakistan. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Hospitalization, Vaccine Efficacy. Die Arbeit nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This updated systematic review and meta‐analysis evaluated the relative vaccine effectiveness (rVE) of high‐dose inactivated influenza vaccine (HD‐IV) versus standard‐dose (SD‐IV) in adults ≥ 65 years for key clinical outcomes, including hospitalisations and mortality. Conducted in accordance with PRISMA guidelines, PubMed, Embase, and the Cochrane Library were searched for randomised controlled trials. Primary outcomes were pneumonia and influenza (P&I) hospitalisation, all‐cause hospitalisation, and all‐cause mortality, while secondary outcomes included hospitalisation for cardiorespiratory disease, influenza‐related hospitalisation, laboratory‐confirmed influenza hospitalisation, and serious adverse events (SAEs). Pooled risk ratios (RRs) with 95% confidence intervals (CIs) were estimated using fixed‐effect models. Across 586,188 participants, HD‐IV reduced P&I hospitalisation (rVE 12.0%), increasing to 22.0% in sensitivity analysis. For all‐cause hospitalisation (∼600,000 participants), rVE was 4.0%, while no significant reduction was observed for all‐cause mortality (rVE = 2.0%). Subgroup analyses suggested greater benefits in individuals without cardiovascular disease and those aged 65–79 years. HD‐IV also showed strong protection against influenza‐specific outcomes (rVE 39% for influenza hospitalisation; 32% for laboratory‐confirmed influenza hospitalisation), with no significant difference in SAEs between groups. Overall, HD‐IV provides superior protection compared with SD‐IV against P&I and all‐cause hospitalisation in older adults, with the greatest benefits among younger seniors and those without cardiovascular disease. These findings support prioritising HD‐IV to reduce influenza burden in the elderly, although benefits appear limited in adults aged > 80 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesInfluenza, HumanHospitalizationVaccine EfficacyHumansAgedVaccines, InactivatedAged, 80 and overRandomized Controlled Trials as TopicVaccination

Stichwörter der Autor:innen

high‐dose inactivated influenza vaccinehospitalisationinfluenza vaccinemeta‐analysisolder adults

Substanzen

Influenza VaccinesVaccines, Inactivated

Autor:innen und Institutionen

  • Khyber Medical College, Peshawar, Pakistan.
  • Dow University of Health Sciences, Karachi, Pakistan.
  • Ayub Teaching Hospital, Abbottabad, Pakistan.
  • Rawalpindi Medical University, Punjab, Pakistan.
  • College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq.
  • College of Medicine, University of Baghdad, Baghdad, Iraq.

ORCID-Profile: Bilal Wazir Khan, Sajjad Ghanim Al-Badri, Zaryab Bacha

Zitieren

APA

Khan, B. W., Khattak, M. H., Amjad, M. M., Siddiqui, S. A., Qazi, T. I., Rehmat, H., Khan, M. F., Khan, H. W., Mian, A. M., Ullah, M., Khan, U. Z., Rafay, M. A., Al-Badri, S. G., & Bacha, Z. (2026). Comparative Effectiveness of High‐Dose and Standard‐Dose Influenza Vaccines for Hospitalisation and Mortality in Adults Aged 65 and Older: An Updated Systematic Review and Meta‐Analysis. Reviews in Medical Virology, 36(3). https://doi.org/10.1002/rmv.70158

Vancouver

Khan BW, Khattak MH, Amjad MM, Siddiqui SA, Qazi TI, Rehmat H, et al. Comparative Effectiveness of High‐Dose and Standard‐Dose Influenza Vaccines for Hospitalisation and Mortality in Adults Aged 65 and Older: An Updated Systematic Review and Meta‐Analysis. Reviews in Medical Virology. 2026;36(3). doi:10.1002/rmv.70158

BibTeX
@article{Khan2026,
  author = {Khan, Bilal Wazir and Khattak, Muhammad Huzaifa and Amjad, Muhammad Maaz and Siddiqui, Shahreena Athar and Qazi, Tayyaba Ikram and Rehmat, Hamdullah and Khan, Muhammad Faaz and Khan, Haris Wazir and Mian, Affan Masaud and Ullah, Mohsin and Khan, Umer Zaryab and Rafay, Muhammad Abdur and Al-Badri, Sajjad Ghanim and Bacha, Zaryab},
  title = {Comparative Effectiveness of High‐Dose and Standard‐Dose Influenza Vaccines for Hospitalisation and Mortality in Adults Aged 65 and Older: An Updated Systematic Review and Meta‐Analysis},
  journal = {Reviews in Medical Virology},
  year = {2026},
  volume = {36},
  number = {3},
  doi = {10.1002/rmv.70158}
}
Kostenlos starten →